Showing results (841-850 of 1,383) with videos related to
Sort By:
Pageof 139
ACS Pharmacology & Translational Science|April 16, 2021
Structure-Activity Relationship Analysis of Psychedelics in a Rat Model of Asthma Reveals the Anti-Inflammatory PharmacophoreThomas W Flanagan, Gerald B Billac, Alexus N Landry, et al.ACS Pharmacology & Translational Science|April 16, 2021
Psilocybin-Assisted Group Therapy and Attachment: Observed Reduction in Attachment Anxiety and Influences of Attachment Insecurity on the Psilocybin ExperienceChristopher S Stauffer, Brian T Anderson, Kile M Ortigo, et al.ACS Pharmacology & Translational Science|April 16, 2021
Investigation of the Structure-Activity Relationships of Psilocybin AnaloguesAdam K Klein, Muhammad Chatha, Lauren J Laskowski, et al.ACS Pharmacology & Translational Science|April 16, 2021
Ultrasound-Responsive Nanocarriers in Cancer Treatment: A ReviewNahid S Awad, Vinod Paul, Nour M AlSawaftah, et al.ACS Pharmacology & Translational Science|April 16, 2021
A Review of Small-Molecule Inhibitors of One-Carbon Enzymes: SHMT2 and MTHFD2 in the SpotlightChristine R Cuthbertson, Zahra Arabzada, Armand Bankhead, et al.ACS Pharmacology & Translational Science|April 16, 2021
Identification of Small-Molecule Inhibitors of Human Inositol Hexakisphosphate Kinases by High-Throughput ScreeningGangling Liao, Wenjuan Ye, Tyler Heitmann, et al.ACS Pharmacology & Translational Science|April 16, 2021
Proadrenomedullin N-Terminal 20 Peptides (PAMPs) Are Agonists of the Chemokine Scavenger Receptor ACKR3/CXCR7Max Meyrath, Christie B Palmer, Nathan Reynders, et al.ACS Pharmacology & Translational Science|April 16, 2021
Design, Synthesis, Pharmacokinetics, and Biodistribution of a Series of Bone-Targeting EP4 Receptor Agonist Prodrugs for Treatment of Osteoporosis and Other Bone ConditionsMarion Thévenin, Gang Chen, Srinivas Kantham, et al.ACS Pharmacology & Translational Science|April 16, 2021
Lipophilicity Determines Routes of Uptake and Clearance, and Toxicity of an Alpha-Particle-Emitting Peptide Receptor RadiotherapyNarges K Tafreshi, HyunJoo Kil, Darpan N Pandya, et al.ACS Pharmacology & Translational Science|April 16, 2021
SARS-CoV-2 Glycosylation Suggests That Vaccines Should Have Adopted the S1 Subunit as AntigenAriel FernándezPageof 139